bf/NYSE:MED_icon.jpeg

NYSE:MED

Medifast, Inc.

  • Stock

USD

Last Close

19.15

25/09 14:39

Market Cap

204.85M

Beta: 1.27

Volume Today

34.47K

Avg: 241.26K

PE Ratio

4.73

PFCF: 3.26

Dividend Yield

9.50%

Payout:60.85%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
19.43M
-
16.90M
13.04%
14.54M
13.98%
15.82M
8.86%
18.82M
18.94%
29.11M
54.67%
43.83M
50.58%
51.08M
16.55%
116.72M
128.49%
149.45M
28.04%
86.72M
41.97%
average payables
21.42M
-
18.24M
14.86%
22.18M
21.62%
23.40M
5.51%
30.72M
31.27%
48.73M
58.63%
41.47M
14.91%
29.19M
29.61%
53.33M
82.72%
64.78M
21.47%
48.93M
24.47%
average receivables
1.70M
-
1.45M
14.67%
1.64M
13.36%
1.51M
8.01%
981.50K
35%
793.50K
19.15%
1.22M
54.25%
1.01M
17.44%
292K
71.10%
4.36M
-
book value per share
7.15
-
6.35
11.11%
7.41
16.62%
8.11
9.46%
9.11
12.31%
9.13
0.29%
8.91
2.48%
13.36
50.00%
17.30
29.49%
13.85
19.94%
18.45
33.21%
capex per share
-0.84
-
-0.55
34.21%
-0.24
57.48%
-0.24
3.03%
-0.27
11.95%
-0.41
52.08%
-0.85
106.65%
-0.50
41.47%
-2.92
484.37%
-1.49
49.02%
-0.59
60.16%
capex to depreciation
-1.02
-
-0.87
14.45%
-0.40
54.58%
-0.53
34.30%
-0.77
44.76%
-1.11
44.61%
-2.18
95.28%
-0.81
62.77%
-5.02
520.16%
-1.52
69.75%
-0.49
67.44%
capex to operating cash flow
-0.27
-
-0.28
0.39%
-0.10
65.15%
-0.11
18.37%
-0.07
33.91%
-0.08
8.33%
-0.12
46.95%
-0.04
66.03%
-0.36
792.41%
-0.09
76.31%
-0.04
48.79%
capex to revenue
-0.03
-
-0.02
24.29%
-0.01
58.03%
-0.01
1.37%
-0.01
2.62%
-0.01
8.28%
-0.01
42.93%
-0.01
55.32%
-0.02
255.96%
-0.01
53.45%
-0.01
42.05%
cash per share
4.92
-
4.15
15.59%
5.61
35.06%
6.49
15.65%
8.29
27.73%
8.46
2.03%
7.87
6.90%
14.82
88.26%
9.36
36.86%
7.83
16.32%
13.74
75.44%
days of inventory on hand
74.03
-
75.49
1.98%
68.11
9.77%
97.05
42.48%
95.66
1.43%
117.21
22.53%
100.68
14.10%
82.22
18.34%
164.91
100.58%
94.69
42.58%
67.27
28.96%
days payables outstanding
59.93
-
104.85
74.96%
114.95
9.63%
128.79
12.04%
183.81
42.72%
181.81
1.09%
46.67
74.33%
55.08
18.02%
64.94
17.90%
46.74
28.02%
48.30
3.33%
days sales outstanding
1.27
-
2.11
65.66%
2.19
3.51%
1.84
15.61%
0.70
62.19%
0.74
5.65%
0.73
0.22%
0.23
68.97%
2.97
-
debt to assets
0.01
-
0.00
22.06%
2.46
59,971.84%
0.01
99.74%
0.07
-
0.04
42.14%
0.08
102.10%
0.08
0.84%
0.07
13.79%
debt to equity
0.01
-
0.01
16.71%
3.25
55,140.22%
0.01
99.75%
0.13
-
0.07
45.29%
0.16
126.45%
0.17
4.54%
0.11
34.98%
dividend yield
0.02
-
0.02
23.34%
0.02
16.13%
0.03
76.97%
0.02
16.13%
0.03
13.18%
0.06
112.91%
0.10
79.34%
earnings yield
0.07
-
0.03
53.44%
0.06
78.05%
0.04
34.47%
0.03
7.95%
0.04
12.16%
0.06
61.72%
0.04
26.32%
0.07
50.35%
0.11
66.15%
0.14
21.81%
enterprise value
324.23M
-
401.11M
23.71%
321.50M
19.85%
441.33M
37.27%
757.34M
71.61%
1.41B
86.48%
1.23B
13.15%
2.16B
75.99%
2.38B
10.25%
1.23B
48.33%
661.68M
46.19%
enterprise value over ebitda
7.21
-
13.26
83.94%
11.21
15.48%
16.43
46.60%
19.11
16.30%
20.45
7.01%
13.47
34.12%
16.09
19.43%
10.67
33.69%
6.28
41.13%
4.74
24.49%
ev to operating cash flow
7.65
-
15.71
105.21%
10.93
30.41%
17.41
59.26%
17.52
0.61%
23.22
32.57%
14.56
37.32%
14.87
2.13%
25.17
69.31%
6.32
74.89%
4.48
29.10%
ev to sales
0.91
-
1.41
54.76%
1.18
16.17%
1.61
36.39%
2.51
56.22%
2.82
12.24%
1.72
39.03%
2.31
34.36%
1.56
32.47%
0.77
50.67%
0.62
19.76%
free cash flow per share
2.23
-
1.46
34.56%
2.22
52.19%
1.90
14.65%
3.35
76.74%
4.68
39.44%
6.30
34.79%
11.83
87.74%
5.15
56.44%
15.89
208.26%
12.93
18.65%
free cash flow yield
0.09
-
0.04
49.04%
0.07
68.07%
0.05
37.71%
0.05
5.39%
0.04
22.14%
0.06
53.78%
0.06
4.78%
0.02
59.17%
0.14
459.68%
0.19
39.60%
graham net net
3.16
-
2.08
34.28%
3.87
86.24%
5.22
35.01%
6.00
14.95%
5.10
15.07%
2.41
52.81%
7.03
192.27%
0.32
95.49%
-1.26
496.23%
6.91
649.62%
graham number
16.73
-
12.19
27.10%
16.72
37.12%
16.58
0.86%
21.82
31.67%
30.98
41.93%
36.42
17.57%
51.25
40.72%
73.85
44.10%
63.22
14.40%
61.47
2.76%
income quality
1.77
-
1.21
31.29%
1.50
23.78%
1.42
5.44%
1.56
9.73%
1.09
30.11%
1.08
0.80%
1.41
30.53%
0.58
59.17%
1.36
135.13%
1.49
9.59%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
66.38
-
42.24
36.37%
43.39
2.73%
94.91
118.71%
71.03
25.16%
52.88
25.55%
-263.63
-
interest debt per share
0.09
-
0.09
7.63%
24.16
25,619.14%
0.09
99.63%
0.05
47.82%
0.11
133.60%
1.16
957.00%
0.95
17.94%
2.78
193.22%
2.26
18.55%
2.02
10.99%
inventory turnover
4.93
-
4.83
1.94%
5.36
10.83%
3.76
29.81%
3.82
1.45%
3.11
18.39%
3.63
16.42%
4.44
22.45%
2.21
50.14%
3.85
74.16%
5.43
40.76%
invested capital
0.01
-
0.01
16.71%
3.25
55,140.22%
0.01
99.75%
0.13
-
0.07
45.29%
0.16
126.45%
0.17
4.54%
0.11
34.98%
market cap
359.92M
-
425.09M
18.11%
363.32M
14.53%
492.98M
35.69%
832.41M
68.85%
1.49B
79.43%
1.29B
13.64%
2.31B
79.18%
2.45B
6.07%
1.29B
47.32%
734.11M
43.15%
net current asset value
57.72M
-
46.48M
19.47%
59.33M
27.65%
76.10M
28.26%
87.85M
15.44%
85.20M
3.02%
64.33M
24.49%
115.48M
79.51%
111.01M
3.86%
61.62M
44.50%
115.60M
87.62%
net debt to ebitda
-0.79
-
-0.79
0.07%
-1.46
83.84%
-1.92
31.92%
-1.89
1.50%
-1.18
37.81%
-0.70
40.91%
-1.14
63.36%
-0.32
71.76%
-0.31
1.98%
-0.52
64.90%
net income per share
1.74
-
1.04
40.22%
1.68
61.22%
1.51
10.20%
2.32
54.36%
4.67
100.86%
6.62
41.75%
8.74
32.01%
14.01
60.37%
12.82
8.49%
9.10
29.02%
operating cash flow per share
3.08
-
2.02
34.47%
2.46
22.02%
2.14
12.95%
3.63
69.39%
5.09
40.39%
7.16
40.62%
12.34
72.32%
8.08
34.52%
17.38
115.17%
13.52
22.21%
payables turnover
6.09
-
3.48
42.84%
3.18
8.79%
2.83
10.74%
1.99
29.93%
2.01
1.10%
7.82
289.56%
6.63
15.27%
5.62
15.18%
7.81
38.94%
7.56
3.23%
receivables turnover
286.43
-
172.90
39.64%
167.04
3.39%
197.93
18.50%
523.55
164.51%
495.55
5.35%
496.64
0.22%
1.60K
222.32%
122.84
-
research and ddevelopement to revenue
return on tangible assets
0.18
-
0.11
37.07%
0.17
50.34%
0.15
13.94%
0.19
29.11%
0.33
73.34%
0.40
21.56%
0.37
6.92%
0.41
10.53%
0.45
10.25%
0.32
29.35%
revenue per share
25.91
-
22.52
13.10%
22.81
1.30%
23.18
1.64%
25.29
9.09%
41.94
65.82%
60.63
44.58%
79.42
30.99%
130.38
64.17%
142.79
9.52%
98.16
31.25%
roe
0.24
-
0.16
32.75%
0.23
38.25%
0.19
17.97%
0.26
37.44%
0.51
100.28%
0.74
45.36%
0.65
11.99%
0.81
23.85%
0.93
14.30%
0.49
46.71%
roic
0.24
-
0.25
4.22%
0.05
79.64%
0.18
263.68%
0.25
37.51%
0.50
99.50%
0.58
16.20%
0.57
1.60%
0.61
7.17%
0.70
13.45%
0.40
42.89%
sales general and administrative to revenue
shareholders equity per share
7.15
-
6.35
11.11%
7.41
16.62%
8.11
9.46%
9.11
12.31%
9.13
0.29%
8.91
2.48%
13.36
50.00%
17.30
29.49%
13.85
19.94%
18.45
33.21%
stock based compensation to revenue
0.01
-
0.01
52.74%
0.01
17.76%
0.01
10.55%
0.01
13.32%
0.01
55.93%
0.01
1.57%
0.01
14.78%
0.01
10.74%
0.01
6.55%
0.01
10.46%
tangible asset value
98.42M
-
80.48M
18.23%
88.58M
10.08%
96.02M
8.39%
108.58M
13.09%
109.11M
0.48%
104.83M
3.92%
157.25M
50.00%
202.47M
28.76%
155.04M
23.43%
201.48M
29.95%
tangible book value per share
7.15
-
6.35
11.11%
7.41
16.62%
8.11
9.46%
9.11
12.31%
9.13
0.29%
8.91
2.48%
13.36
50.00%
17.30
29.49%
13.85
19.94%
18.45
33.21%
working capital
64.85M
-
54.97M
15.24%
64.51M
17.35%
76.88M
19.17%
88.06M
14.55%
85.20M
3.25%
74.76M
12.25%
122.96M
64.47%
137.03M
11.44%
81.89M
40.24%
131.73M
60.86%

All numbers in USD (except ratios and percentages)